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Introduction: With growing awareness of the importance of rehabilitation, new measures are being developed
specifically for use in the intensive care unit (ICU). There are currently 26 measures reported to assess function in
ICU survivors. The Physical Function in Intensive care Test scored (PFIT-s) has established clinimetric properties. It is
unknown how other functional measures perform in comparison to the PFIT-s or which functional measure may be
the most clinically applicable for use within the ICU. The aims of this study were to determine (1) the criterion validity
of the Functional Status Score for the ICU (FSS-ICU), ICU Mobility Scale (IMS) and Short Physical Performance Battery
(SPPB) against the PFIT-s; (2) the construct validity of these tests against muscle strength; (3) predictive utility of these
tests to predict discharge to home; and (4) the clinical applicability. This was a nested study within an ongoing
controlled study and an observational study.
Methods: Sixty-six individuals were assessed at awakening and ICU discharge. Measures included: PFIT-s, FSS-ICU, IMS
and SPPB. Bivariate relationships (Spearman’s rank correlation coefficient) and predictive validity (logistic regression)
were determined. Responsiveness (effect sizes); floor and ceiling effects; and minimal important differences were
calculated.
Results: Mean ± SD PFIT-s at awakening was 4.7 ± 2.3 out of 10. On awakening a large positive relationship existed
between PFIT-s and the other functional measures: FSS-ICU (rho = 0.87, p < 0.005), IMS (rho = 0.81, p < 0.005) and SPPB
(rho = 0.70, p < 0.005). The PFIT-s had excellent construct validity (rho = 0.8, p < 0.005) and FSS-ICU (rho = 0.69, p < 0.005)
and IMS (rho = 0.57, p < 0.005) had moderate construct validity with muscle strength. The PFIT-s and FSS-ICU had small
floor/ceiling effects <11% at awakening and ICU discharge. The SPPB had a large floor effect at awakening (78%) and
ICU discharge (56%). All tests demonstrated responsiveness; however highest effect size was seen in the PFIT-s (Cohen’s
d = 0.71).
Conclusions: There is high criterion validity for other functional measures against the PFIT-s. The PFIT-s and FSS-ICU are
promising functional measures and are recommended to measure function within the ICU.
Trial registration: Clinicaltrials.gov NCT02214823. Registered 7 August 2014).Introduction
Impairment in physical function is a significant problem
for survivors of critical illness [1-3]. Physical function re-
fers to ‘the ability to carry out various activities that re-
quire physical capability ranging from self-care to more
vigorous activities that require increasing degrees of
mobility, strength or enduranceʼ [4]. The International
Classification of Functioning (ICF) framework provides a
conceptual model to guide patient assessment, which* Correspondence: parrys@unimelb.edu.au
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and participation restrictions [2,5]. In survivors of crit-
ical illness, measurement of physical function using
performance-based tests provides information on the pa-
tients’ activity limitations. There are currently 26 self-
report and performance-based measures reported in the
literature to assess physical function in ICU survivors [6].
When selecting the most appropriate outcome meas-
ure to assess physical function, clinicians and researchers
need to consider which outcome measures have robust
clinimetric properties [2]. This includes the ability of an
outcome measure to measure what it is intended to
measure, that is, how well the test results relate to datahis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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concurrent validity); how well the outcome obtains data,
as hypothesized, when compared to an instrument meas-
uring a similar construct (convergent or construct valid-
ity); or how well data predict an outcome (predictive
validity/utility) [7,8]. Additionally, the clinical applicability
of the outcome measure is also important. This includes
whether there is a floor or ceiling effect; the ability of the
outcome measure to detect meaningful change over time
(responsiveness) [8]; and whether there is a known min-
imal important difference (the smallest change in the out-
come measure that patients and clinicians consider to be
clinically relevant) [9]. These clinimetric properties should
be examined specifically within the setting in which the
outcome measure will be used [10]. This is particularly
important for a challenging environment such as ICU,
where fluctuations in patient mental alertness, ability to
follow commands, and both rapid changes in medical sta-
bility and a confined space may impact on the choice, reli-
ability and validity of outcome measures [2,11,12].
Whilst 26 different functional measures have been de-
scribed for use within critically ill patients, there are cur-
rently only six published functional measures that have
been developed specifically for the ICU setting and have
undergone clinimetric evaluation [6]. These measures
are the Physical Function in Intensive care Test scored
(PFIT-s) [13], Chelsea Critical Care Physical Assessment
tool (CPAx) [14], Perme mobility scale [15], Surgical in-
tensive care unit Optimal Mobilization Score (SOMS)
[16], ICU Mobility Scale (IMS) [17], and the Functional
Status Score for the ICU (FSS-ICU) [18,19]. To date,
studies of clinimetric properties have been primarily lim-
ited to a single component, such as reliability testing [6].
There is also growing interest in the application of the
Short Physical Performance Battery (SPPB) [20] or its
components [21] to evaluate functional recovery in indi-
viduals with critical illness. The SPPB is a battery tool,
originally developed for use in the geriatric population
[22,23] and may discriminate between individuals with
critical illness who receive early rehabilitation versus
usual care [20]. However, there have been no published
studies on the SPPB examining specifically the clini-
metric properties of this test within the ICU setting.
The clinimetric properties of functional measures for
use within the ICU setting are still in early development.
The PFIT-s [13,24] and CPAx tools [14,25] have the
most established clinimetric properties in terms of reli-
ability, validity and responsiveness. The PFIT-s can be
used to guide exercise prescription within the ICU as
well as measuring functional recovery [13,26]. The PFIT-s
can be used as a reference standard against which other
functional measures can be compared.
Three functional measures, which were selected for
comparison against the PFIT-s within this study, were:FSS-ICU, IMS and the SPPB. It is unknown how these
other functional measures perform in comparison to the
PFIT-s or which of these four functional measures may
be the most clinically applicable for use within the ICU.
Therefore, the aims of this study were to determine (1)
the criterion validity of the FSS-ICU, IMS and SPPB
against the PFIT-s; (2) the construct validity of these out-
come measures against measurement of muscle strength;
(3) the predictive utility of these outcome measures to
predict patients who would discharge directly home from
hospital; and (4) the clinical applicability of the outcome
measures (floor and ceiling effects, responsiveness and
minimal important difference). It was hypothesized that
the FSS-ICU would have the strongest positive correlation
with the PFIT-s (correlation >0.50). The COnsensus-based
Standards for the selection of health status Measurement
INstruments (COSMIN) guidelines [27] and the Strength-
ening the Reporting of Observational Studies in Epidemi-
ology (STROBE) guidelines [28] were followed in reporting
this study.
Materials and methods
Study design, setting and participants
This was a nested observational study within an ongoing
controlled trial (NCT02214823) and an observational
study conducted in major mixed (medical and surgical)
ICUs in Melbourne, Australia. Consecutive participants
were recruited between July 2012 and June 2014 for the
two main trials. Both sites had institutional ethical ap-
proval (Melbourne Health and Austin Health Human
Research Ethics Committees) and participants provided
written informed consent. Participants were included in
the primary trials if they were admitted to an ICU, were
more than 18 years old, English speaking, and were
mechanically ventilated for 48 hours and expected to re-
main in the unit for at least four days. Patients were ex-
cluded from the primary trials if they had a premorbid
physical or cognitive impairment that would prevent ex-
ercise, or were admitted with a new neurological insult
such as stroke or spinal cord injury. All patients were re-
quired to be able to ambulate at least 10-metres inde-
pendently prior to ICU admission (+/− gait aid). Patients
were included in the nested study as a convenience sam-
ple if they had been assessed at both awakening and ICU
discharge.
Procedure
Assessments were performed twice in the ICU for each
patient: on awakening and ICU discharge. Day of awak-
ening was defined as when the patient scored greater
than three out of five on the De Jonghe comprehension
criteria on two consecutive occasions within a 6-hour
period [29]. Between the two time points of testing
(awakening and ICU discharge), patients received usual-
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as active exercises in bed, sitting on the edge of the bed,
standing, marching, and walking. At each time point of
testing, the participants completed the PFIT-s and a range
of additional functional tests (FSS-ICU, IMS, SPPB). The
Medical Research Council-Sum Score (MRC-SS) [30] was
assessed at awakening in order to determine the incidence
of ICU-acquired weakness (ICU-AW) within the popula-
tion studied. The order of testing varied, and was not con-
trolled within this study. In order to minimize fatigue as
an issue, all tests were completed within a 12-hour period,
and participants were required to return to baseline based
on clinical parameters such as heart rate, respiratory rate
and oxygen saturation levels before the next functional
test was undertaken. Patients were stable and unchanged
in the time between completing the PFIT-s and additional
functional tests. All assessors were qualified physical ther-
apists and had received standardized training in the out-
come measures (PFIT-s, SPPB, FSS-ICU, IMS, MRC-SS)
from one senior physical therapist. The same assessor
(where possible) performed awakening and ICU discharge
measures within the same patient.
Physical function in intensive care test scored
The PFIT-s is a battery outcome measure involving four
components: sit to stand assistance, marching on the spot
cadence, shoulder flexor and knee extensor strength. The
PFIT-s scores range from 0 (able to perform strength test-
ing only with a maximum score of 2 out of 5 for shoulder
and knee) to 10 (performance without any difficulty)
[13,31]. This tool has established validity, reliability and a
minimal clinically important difference (MCID) of 1.5
points out of 10 [13,31].
Additional outcome measures
Participants also completed three additional functional
measures: the FSS-ICU, IMS and SPPB. The FSS-ICU
involves assessment of five functional tasks (rolling, su-
pine to sit transfers, unsupported sitting, sit to stand
transfers, and ambulation). The five tasks are scored on
a seven-point scoring system from the Functional Inde-
pendence Measure [18,19]. Higher scores represent bet-
ter function and the total score ranges from 0 to 35. The
FSS-ICU was originally developed for use within the
ICU setting [18] however there has been no evaluation
of the clinimetric properties of the FSS-ICU specifically
within the ICU setting. Despite this the FSS-ICU has
been shown to be responsive to change over time and a
valid predictor of discharge destination when imple-
mented in a long-term acute care facility [19].
The IMS is an 11-item categorical scale that rates the
patient's highest level of mobility, where 0 = nothing and
10 = walking independently without a gait aid [17]. Al-
though there is high inter-rater reliability for this measurein the ICU setting, there are no published data on other
clinimetric properties (validity, responsiveness) [17].
The SPPB is a battery tool, which was originally devel-
oped for use in the geriatric population [22,23]. A score
of 0 to 12 (higher scores indicating better function) is
based on the performance of three tasks: gait speed,
chair rise time (five times sit to stand) and standing bal-
ance (tandem, semi-tandem and side by side) [22]. This
is increasingly being used in the ICU setting and to date
there are no published data on the clinimetric properties
or clinical applicability of the SPPB within the ICU
setting.
Baseline demographics were recorded, including age,
sex, body mass index, admission diagnosis and severity
of illness (Acute physiological and chronic health evalu-
ation (APACHE) II within first 24 hours of ICU admis-
sion). Additionally ICU length of stay (LOS), mechanical
ventilation (MV) duration in days, and acute hospital
discharge destination were recorded.
Sample size
The sample size was 66. Sample sizes of ≥50 participants
are recommended for studies assessing clinimetric prop-
erties of measurements to enhance the generalizability
of findings [32,33]. The examination of the SPPB was per-
formed in a subgroup (n = 23) within this nested study.
Only participants from one of the two trials completed
the SPPB. Therefore SPPB analyses are underpowered and
results should be viewed with caution. The measurement
of SPPB was opportunistic to enable preliminary examin-
ation of the clinimetric properties of the SPPB in individ-
uals with critical illness, which had not been reported
within the literature to date.
Statistical analyses
Data were analysed with SPSS Windows Version 22.0
(SPSS, Chicago, IL, USA). Data were assessed for normal-
ity using the Kolmogorov-Smirnov statistic. Parametric
data are presented as mean and SD, and non-parametric
data are presented as median and IQR. Spearman’s rank
correlation coefficient was used to assess the bivariate re-
lationships between test scores (PFIT-s, FSS-ICU, IMS
and SPPB) [7]. Coefficients were interpreted as: little (0.00
to 0.25), fair (0.25 to 0.50), moderate (0.50 to 0.75) and ex-
cellent association (0.75 to 1.0) [8]. Alpha was set at 0.05
for all analyses.
Predictive utility of the tests were assessed using logis-
tic regression analyses to investigate the ability of the
test to predict likelihood of discharge directly to home
compared to other destinations. Logistic regression ana-
lyses were run separately for the PFIT-s, FSS-ICU and
IMS on awakening and ICU discharge (SPPB was not
assessed with logistic regression as this had no bivariate
correlation with discharge destination). The test score
Table 1 Demographics of the cohort
Variable Total sample
(n = 66)
Male, n (%) 40 (61%)
Age, mean ± SD 58 ± 17
Body mass index, kg/m2 median (IQR) 28 (24 to 32)
Acute physiological and chronic health evaluation II,
scorea, mean ± SD
21 ± 7
ICU admission diagnosis
- respiratory, n (%) 14 (21%)
- gastrointestinal, n (%) 12 (18%)
- sepsis, non-pulmonary, n (%) 13 (20%)
- cardiac, n (%) 18 (27%)
- trauma, n (%) 5 (8%)
- other, n (%) 4 (6%)
Medical Research Council (MRC) sum-score on
awakening median (IQR)
48 (39 to 54)
ICU-acquired weakness (<48/60 MRC) on awakening 28 (42%)
ICU length of stay, days, median (IQR) 8 (5 to 15)
Mechanical ventilation time, days, median(IQR) 5 (3 to 10)
Acute hospital discharge destination
- home, n (%) 37 (56%)
- inpatient rehabilitation facility, n (%) 20 (30%)
- deceased in hospital, n (%) 3 (4%)
- other or unknown, n (%) 6 (9%)
Physical function in ICU test scored, on awakening,
mean ± SD
4.7 ± 2.3
Physical function in ICU test scored, at ICU discharge,
mean ± SD
6.3 ± 2.2
Functional status score for ICU, on awakening,
median (IQR)
12.0 (6.0 to 17.0)
Functional status score for ICU, at ICU discharge,
median (IQR)
17.0 (12.0 to 26.5)
ICU mobility scale, on awakening, median (IQR) 3.5 (1.0 to 5.0)
ICU mobility scale, at ICU discharge, median (IQR) 6.0 (5.0 to 8.0)
Short Physical Performance Battery, on awakening,
median (IQR) (n = 23)
0.0 (0.0 to 0.0)
Short Physical Performance Battery, at ICU discharge,
median (IQR) (n = 23)
0.0 (0.0 to 5.0)
aAPACHE II score was determined within the first 24 hours of ICU admission.
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variable) and was included in all regression models. The
outcome of interest (dependent variable) was the dichot-
omous variable of discharge directly to home and was
coded as yes (discharged directly home) or no (not dis-
charged directly home). Potential covariates were: age
(in years), sex (coded as male or female), body mass
index (in kg/m2), APACHE II (in points), MV duration
(in days), MRC-SS on awakening (in points), and ICU
LOS (in days). The potential covariates with significant
bivariate correlation with the dependent variable were
included in the model if collinearity was not identified.
Collinearity was assessed using Spearman’s rank correl-
ation coefficient and defined as rho ≥0.7. Overfitting of
the model was avoided with no more than three inde-
pendent variables included in the final model. Conform-
ity to a linear gradient for variables was examined with
inspection of a plot with locally weighted scatterplot
smoothing (LOWESS). Goodness of fit was examined
using the Hosmer-Lemeshow goodness of fit test and
poor fit was defined as alpha <0.05. In addition the dif-
ferences in test scores on awakening of those partici-
pants discharged directly home versus those discharged
to other destinations were determined using the inde-
pendent t-test for continuous parametric data, the
Mann-Whitney U-test for ordinal non-parametric data
and the Chi-square test for categorical data.
Floor and ceiling effects of the PFIT-s, FSS-ICU, IMS
and SPPB were determined using the percentage of occa-
sions when participants scored the lowest or highest score
possible for the test. Change over time, from awakening to
ICU discharge, was assessed using the paired t-test for
parametric data [8] and the Wilcoxon signed rank test for
non-parametric data [8]. Responsiveness of each test was
determined with calculation of the effect size. For para-
metric data this was defined as Cohen’s d and calculated
as the mean difference divided by pooled SD [34]. For
non-parametric data this was defined as r = Z divided by
the square root of the sample size [8,34]. Thresholds for
interpretation of the change were: small (0.2 to 0.49),
moderate (0.5 to 0.79) and large (≥0.8) [34,35].
The minimal important differences (MIDs) of the
continuous and ordinal tests were determined using
distribution-based estimation with calculation of the
standard error of the measurement (SEM) and effect size
(ES). The SEM was calculated as σ1√(1-r), where σ1 was
the baseline SD of the test score and r was the test-retest
reliability coefficient of the test [36]. A moderate ES is
considered a clinically important effect and was calculated
using the formula 0.5 × SD of the change scores [37].
Results
The PFIT-s and additional functional tests were con-
ducted with 66 patients. The characteristics of thecohort studied are reported in Table 1. All participants
were previously independent and prior to hospitalization
in the ICU were from home. The mean ± SD PFIT-s on
awakening was 4.7 ± 2.3 out of 10 (Table 1).
Validity
There was moderate to large criterion validity between
the PFIT-s and the three other functional tests (Figure 1).
On awakening large positive relationships existed be-
tween PFIT-s and the FSS-ICU (n = 66, rho = 0.87, 95%
Figure 1 Relationship between physical function in intensive care test scored (PFIT-s) and (a) Functional Status Score for the Intensive
Care Unit (FSS-ICU), (b) Short Physical Performance Battery (SPPB) and (c) ICU mobility scale (IMS) on awakening.
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rho = 0.81, 95% CI = 0.70, 0.88, P <0.005) (Figure 1c);
and a moderate positive relationship existed between the
PFIT-s and SPPB (n = 23, rho = 0.70, 95% CI = 0.47, 0.83,
P <0.005) (Figure 1b). At ICU discharge large positive re-
lationships existed between PFIT-s and FSS-ICU (n = 66,
rho = 0.85, 95% CI = 0.77, 0.90, P <0.005) and SPPB (n = 23,
rho = 0.86, 95% CI = 0.73, 0.91, P <0.005); and a moderate
positive relationship existed between the PFIT-s and IMS
(n = 64, rho = 0.66, 95% CI = 0.49, 0.80, P <0.005).
The PFIT-s demonstrated excellent construct validity
with measurement of muscle strength: on awakening a
large positive relationship existed between the PFIT-s
and MRC sum-score (n = 66, rho = 0.8, 95% CI = 0.68,
0.89, P <0.005). In addition, moderate positive relationships
existed between FSS-ICU and MRC sum-score (n = 66,
rho = 0.69, 95% CI = 0.50, 0.83, P <0.005), and between
IMS and MRC sum-score (n = 66, rho = 0.57, 95% CI =
0.36, 0.74, P <0.005). There was no relationship between
SPPB and MRC sum-score on awakening (n = 23, rho =
0.30, 95% CI = −0.08, 0.62, P = 0.161).
Predictive utility
Fifty-six percent (n = 37) of participants were dis-
charged directly home from their acute hospital stay
(Table 1). Higher PFIT-s scores on awakening (oddsratio (OR) = 1.59, P = 0.004) and lower age were signifi-
cant factors in determining whether the patient was
discharged directly home (Additional file 1: Table S1);
this was not found for FSS-ICU (P = 0.642) or IMS (P =
0.143) when assessed on awakening. Lower age and higher
test scores at ICU discharge were significant factors in
determining discharge to home: PFIT-s (OR = 1.56, P =
0.005), FSS-ICU (OR = 1.09, P = 0.013) and IMS (OR =
1.54, P = 0.011) (Additional file 1: Table S1). There was a
significant difference in the PFIT-s, IMS and FSS-ICU
scores on awakening between participants who were dis-
charged home from the acute hospital versus those who
were discharged to another location (P <0.05), this was
not the case for the SPPB (P >0.05).
Clinical applicability
Table 2 provides the floor and ceiling effects for each
test, as well as the range of test scores at both awakening
and ICU discharge.
There were significant improvements from awakening to
ICU discharge in the PFIT-s (mean difference = 1.59, 95%
CI = 1.12, 2.06, P <0.005), FSS-ICU (Z = −5.34, P <0.005),
IMS (Z = −6.71, P <0 0.005) and SPPB (Z = −2.23, p =
0.026). All tests demonstrated responsiveness to change,
however the highest effect size was seen for the PFIT-s:
The effect sizes of the PFIT-s and IMS were 0.71 and 0.59
Table 2 Floor and ceiling effects




Range of test scores
at each time point
PFIT-s on awakening 6/66 (9.1%) 1/66 (1.5%) 0 to 10 out of 10
PFIT-s at ICU discharge 1/66 (1.5%) 7/66 (10.6%) 0 to 10 out of 10
FSS-ICU on awakening 2/66 (3.0%) 0/66 (0%) 0 to 33 out of 35
FSS-ICU at ICU discharge 0/66 (0%) 2/66 (3.0%) 2 to 35 out of 35
IMS on awakening 11/66 (16.7%) 0/66 (0%) 0 to 8 out of 10
IMS at ICU discharge 0/64 (0%) 3/64 (4.7%) 1 to 10 out of 10
SPPB on awakening 18/23 (82.6%) 0/23 (0%) 0 to 8 out of 12
SPPB at ICU discharge 13/23 (56.5%) 0/23 (0%) 0 to 11 out of 12
FSS-ICU, Functional Status Score for the Intensive Care Unit; IMS, ICU mobility scale; n, number; PFIT-s, Physical Function in Intensive Care Test scored; SPPB, Short
Physical Performance Battery.
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to change. The effect sizes of the FSS-ICU and SPPB were
0.46 and 0.33 respectively, which represent small respon-
siveness to change.
The minimal important differences for the three tests
were estimated to be between 1.0 to 1.4 points for the
PFIT-s, 4.3 to 5.6 points for the FSS-ICU, and 1.5 to 1.3
points for the SPPB according to calculation of the ES
and SEM respectively.
Discussion
Physical function is an important outcome to measure
in survivors of critical illness. In a moderately unwell co-
hort of ICU survivors from two mixed medical/surgical
ICUs we found that there was high criterion validity for
other functional measures against the PFIT-s especially
for the FSS-ICU tool. The PFIT-s had strong construct
validity with measurement of muscle strength, and both
the FSS-ICU and IMS had moderate construct validity.
There was no relationship between SPPB and muscle
strength at awakening or ICU discharge. All functional
measures except the SPPB were able to discriminate and
predict future discharge destination.
The PFIT-s had high construct validity with muscle
strength and was predictive of discharge destination
when measured on awakening or at ICU discharge. This
is in consensus with what has previously been reported
within the ICU literature [13,31]. The MID for the PFIT-s
was estimated to be between 1.0 to 1.4 points in this
study, which was similar to that reported by Denehy and
colleagues in 2013 (1.5 points out of 10.0) [13] adding fur-
ther validity to the cutoff point previously developed. The
floor and ceiling effects for the PFIT-s were small in our
study (9 and 11% respectively). This is in contrast to previ-
ous studies, which reported a floor effect of 22 to 32% on
awakening and a ceiling effect of 5 to 22% respectively
[13,31]. The differences may in part be due to differences
in patient cohort demographics and sedation practicesand provisions of therapy within the units. In comparison
to the study by Nordon-Craft and colleagues [31] there
was a marked difference in overall MV duration and ICU
LOS compared to our study (median MV duration of
12 days and ICU LOS of 20 days versus MV duration of
5 days and ICU LOS of 8 days). There was a large floor ef-
fect observed at baseline by Nordon-Craft and colleagues
(32%) [31] compared to our study with a floor effect of 9%
on awakening. Similar to the findings of Denehy and col-
leagues [13] this paper identified that a higher PFIT-s (bet-
ter function) predicted a greater likelihood of return to
home. The demographics within the Australian study [13]
were more comparable to the sample examined within
our study.
Compared to the PFIT-s the FSS-ICU was the most
robust functional outcome measure in the ICU setting.
It was predictive of discharge destination when tested at
ICU discharge and had small floor/ceiling effects within
the ICU setting. Floor and ceiling effects are of concern
for longitudinal studies as they limit the ability to detect
change over time in terms of improvement and/or de-
terioration in functional recovery [7]. The floor effect
observed at awakening was less than 15% (the acceptable
cutoff for outcome measures) [38] for the PFIT-s and
FSS-ICU (<10%). In contrast there was a large floor ef-
fect for SPPB on awakening and ICU discharge time
points and a moderate floor effect at ICU awakening for
IMS (17%).
The SPPB is a high-level physical function outcome as
it examines gait speed, balance control and sit-to-stand
repetitions. Although power was not achieved for the
SPPB outcome, large floor effects were observed for the
SPPB suggesting it may not be a feasible measure for use
within the ICU setting. Floor and ceiling effects are in-
fluenced by patient characteristics and therefore differ-
ences in sample characteristics may affect the choice of
test used to evaluate physical function. For example the
SPPB contains tasks requiring higher-level functional
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which may be more sensitive in individuals with greater
severity of illness and impairment to be able to detect
change over time in the early ICU admission period. It is
important that patient characteristics are considered
when selecting a test. The SPPB may be more appropri-
ate as a measure in the post ICU setting in the acute
hospital wards or post hospital discharge.
The minimal important difference is the smallest
change in an outcome that is considered to be clinically
relevant [9]. There are two main methods used to deter-
mine the minimal important difference, the distribution-
based method and the anchor-based method [39]. The
distribution-based method utilizes statistical analyses to
determine the minimal important difference using the
degree of test score variability. The main disadvantage
with this method is that it does not take into account
whether the clinician or patient feels that change is clin-
ically meaningful [40]. The anchor-based estimation
takes into account a patient-related anchor such as the
global rating of change scale to determine if the patient
is clinically changed [39]. Future studies need to deter-
mine whether the cutoff values developed using the
distribution-based methods remain stable when applying
the anchor-based methods and demonstrate a change
that is clinically meaningful.
Higher PFIT-s scores (better function) were shown to
be predictive of discharge to home on both awakening
and ICU discharge time points. Higher FSS-ICU and
IMS scores were predictive of discharge to home only at
ICU discharge. The differences in the predictive validity
of the functional outcomes at the two time points may
relate to differences in the individual constructs mea-
sured within each measure. The PFIT-s involves evalu-
ation of peripheral muscle strength (shoulder flexion
and knee extension); sit to stand assistance and march-
ing in place cadence. In contrast the IMS and FSS-ICU
examine a hierarchical level of dependence/assistance re-
quired to perform functional tasks such as bed mobility,
sitting, standing and walking. Physical function is a com-
plex entity to measure and can encompass a range of
different constructs. Therefore, in the future it is import-
ant that within functional tests we consider what the in-
dividual constructs of a functional test are able to tell us
about a patient’s future trajectory of recovery and the
prediction of discharge to home and resumption of fam-
ily, societal and community roles.
In addition to consideration of the clinimetric proper-
ties of outcome measures it is important to consider
other aspects of utility such as time to complete the
measure, equipment and training required or health pro-
fessional expertise, and availability of the outcome meas-
ure for use in clinical practice. The advantage of the four
functional measures examined within this study is thatthey are readily available, and require little dedicated
equipment (for example, for the PFIT-s a stopwatch is
required for marching in place cadence, or gait aids/
chairs if required for ambulation/sitting out of bed com-
ponents of all functional tests). All outcome measures
take <20 minutes to complete.
Interventions aimed at improving functional recovery
may not only minimize or improve physical function but
may also affect cognitive processing, and emotional
health. Therefore measures that evaluate these aspects
also need to be examined across different time points in
the trajectory of recovery [2,41]. It is important that
there is mapping of outcome measures within the ICF
framework to capture impairment, activity limitation
and participation restrictions across the continuum of
recovery. It is likely in the future that there will be over-
lap in the functional outcomes that are utilized, which
enable sensitive monitoring of functional recovery and
determination of the efficacy of interventional strategies.
The ICU environment is a challenging setting in which
to conduct research, due to patient heterogeneity, sever-
ity of illness, and mortality. To improve the ability to
compare findings between research studies, there is an
urgent need to adopt a standardized core set of outcome
measures. Functional recovery and independence is
complex and requires individuals to master multiple
facets simultaneously [2,41]. For example independent
mobility in the community requires not only muscular
strength, but postural control, endurance, cognitive pro-
cessing to anticipate obstacles and respond to the chan-
ging demands of the environment surrounding them
[2,41]. It is therefore important that outcome measures
are adopted that are setting-specific to ensure improve-
ment and/or deterioration in function are meaningfully
encapsulated to capture changes in impairment, activity
limitations and participation restrictions. For example,
the distance a patient ambulates and level of assistance
does not provide you with information on the quality of
the patient’s ambulation. We hypothesise that there will
not be a single functional outcome that can be utilized
across the continuum of recovery post critical illness. It is
also important to consider different stages of recovery, as
this will vary from patient to patient at different time
points. For example, some patients are able to complete a
6MWT = six minute walk test at hospital discharge, while
others cannot. This will enable the identification of deficits,
which may impact on the ability to discharge home and ul-
timately resume family and societal roles in individuals with
very low levels of function, through to higher-functioning
individuals after the insult of initial critical illness.
Limitations
While combining data from these two studies improved
the generalizability of findings, the overall sample size
Parry et al. Critical Care  (2015) 19:127 Page 8 of 9was small. This study was underpowered to examine the
clinimetric properties of the SPPB and thus, results
should be viewed with caution and interpreted as an
overall trend in findings. Whilst reliability of the func-
tional outcomes was not examined specifically within
this study, the reliability of the PFIT-s and IMS has been
previously reported within individuals with critical ill-
ness [17,42]. Currently there are no published data on
the reliability of the FSS-ICU and this is an area that
needs to be addressed in future research. To our know-
ledge, the reliability of the SPPB scoring has not been re-
ported for individuals with critical illness; it has been
shown to have excellent reliability in the general geriatric
population [43]. Results from logistic regression need to
be validated in an independent sample, and therefore, re-
sults on the ability of the PFIT-s, FSS-ICU and IMS to
predict discharge destination must be viewed with caution.
This study only examined functional measures within
the ICU setting, and the utility of these outcomes in the
post ICU setting warrants further examination. The
CPAx, Perme mobility and SOMS scales were not exam-
ined within this paper and warrant further testing to de-
termine their utility for measuring functional changes
within individuals with critical illness. It is essential that
rigorous examination of currently utilized functional
measures continue to be undertaken in order to determine
the most appropriate outcome/s, which can be utilized
across the continuum of patient recovery specifically for
individuals with critical illness.
Conclusions
There is excellent criterion validity for other functional
measures (FSS-ICU, IMS and SPPB) against the PFIT-s
in the ICU setting. Higher PFIT-s scores on awakening
were predictive of discharge directly home. All tests
were responsive to change, however, the SPPB and IMS
were limited by floor effects when used in the ICU.
Based on the findings in this study the PFIT-s and FSS-
ICU are promising functional measures and should be
considered currently when measuring physical function
in the ICU in clinical practice and research.
Key messages
 Impairment in physical function is a significant
problem for survivors of critical illness.
 PFIT-s and FSS-ICU are promising functional
measures and should be considered when measuring
physical function in the ICU.
 A core set of outcome measures, which map
impairment, activity limitations and participation
restrictions within the ICF framework need to be
developed, which can be utilized across different
time points of recovery.Additional file
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